首页> 外文期刊>Physiological Reports >Suppression of the cough reflex by α2‐adrenergic receptor agonists in the rabbit
【24h】

Suppression of the cough reflex by α2‐adrenergic receptor agonists in the rabbit

机译:α2-肾上腺素能受体激动剂抑制家兔的咳嗽反射

获取原文
           

摘要

AbstractThe α2-adrenergic receptor agonist clonidine has been shown to inhibit citric acid-induced cough responses in guinea pigs when administered by aerosol, but not orally. In contrast, oral or inhaled clonidine had no effect on capsaicin-induced cough and reflex bronchoconstriction in humans. In addition, intravenous administration of clonidine has been shown to depress fentanyl-induced cough in humans. We investigated the effects of the α2-adrenergic receptor agonists, clonidine and tizanidine, on cough responses induced by mechanical and chemical (citric acid) stimulation of the tracheobronchial tree. Drugs were microinjected (30–50 nL) into the caudal nucleus tractus solitarii (cNTS) and the caudal ventral respiratory group (cVRG) as well as administered intravenously in pentobarbital sodium-anesthetized, spontaneously breathing rabbits. Bilateral microinjections of clonidine into the cNTS or the cVRG reduced cough responses at 0.5 mmol/L and abolished the cough reflex at 5 mmol/L. Bilateral microinjections of 0.5 mmol/L tizanidine into the cNTS completely suppressed cough responses, whereas bilateral microinjections of 5 mmol/L into the cVRG only caused mild reductions in them. Depressant effects on the cough reflex of clonidine and tizanidine were completely reverted by microinjections of 10 mmol/L yohimbine. Intravenous administration of clonidine (80–120 μg/kg) or tizanidine (150–300 μg/kg) strongly reduced or completely suppressed cough responses. These effects were reverted by intravenous administration of yohimbine (300 μg/kg). The results demonstrate that activation of α2-adrenergic receptors in the rabbit exerts potent inhibitory effects on the central mechanism generating the cough motor pattern with a clear action at the level of the cNTS and the cVRG.
机译:摘要已证明α 2 -肾上腺素能受体激动剂可乐定在通过气雾剂而非口服给药时可抑制柠檬酸诱导的豚鼠咳嗽反应。相反,口服或吸入可乐定对辣椒素引起的咳嗽和反射性支气管收缩没有作用。另外,可乐定的静脉内给药已显示出抑制人中芬太尼诱导的咳嗽。我们研究了α 2 -肾上腺素能受体激动剂可乐定和替扎尼定对气管支气管树的机械和化学(柠檬酸)刺激诱导的咳嗽反应的影响。将药物微注射(30–50 nL)注入尾状核孤束(cNTS)和尾腹呼吸组(cVRG),并在戊巴比妥钠麻醉的,自发呼吸的兔子中静脉内给药。在cNTS或cVRG中双向注射可乐定可降低0.5 mmol / L的咳嗽反应并消除5 mmol / L的咳嗽反射。双向向cNTS中微量注入0.5mmol / L替扎尼定可完全抑制咳嗽反应,而双向向cVRG中微量注入5mmol / L可使咳嗽反应轻度降低。微量注射10 mmol / L育亨宾可完全恢复可乐定和替扎尼定对咳嗽反射的抑制作用。静脉注射可乐定(80–120μg/ kg)或替扎尼定(150–300μg/ kg)可大大降低或完全抑制咳嗽反应。静脉注射育亨宾(300μg/ kg)可恢复这些作用。结果表明,兔体内α 2 -肾上腺素能受体的激活对产生咳嗽运动模式的中枢机制具有强大的抑制作用,在cNTS和cVRG水平上具有明显的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号